Delivery Order SPE2DB20D2104-SPE2DB23FS44W
- Not listed
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a total ceiling value of $2,154.16. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a ceiling value of $7,669.16. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024, with a delivery order contract type and firm fixed pricing. The contract has an ultimate completion date of August 23, 2024 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award, valued at $1,295.08, is a firm fixed price delivery order for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
- This federal contract award, valued at $1,177.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of Spiriva Respimat 1.25 mcg inhalers. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The fixed-price delivery order, valued at $6,182.15, has an ultimate completion date of September 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication. The $4,374.11 contract is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and is a firm fixed-price award with no set-aside designation. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $79,279.92 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award, with a ceiling value of $1,570.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The contract is for the supply of Spiriva Respimat 1.25 mcg inhalation medication. No set-aside designation was used. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The fixed-price delivery order, valued at $2,705.64, has a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award is for the delivery of Spiriva Respimat 1.25 mcg inhalation solution to the Defense Logistics Agency (DLA). The contract has a value of $1,488.72 and a completion date of May 1, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS44WDelivery Order
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, valued at $1,102.08. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has a ceiling value of $1,102.08 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/2/23 |